The community program supporting COVID-19 patients at home, prestigious awards and grants for Alliance researchers, and a deep dive into genetic data – this week at the Alfred Research Alliance.
Positive care beyond hospital walls
More than 1000 Victorians were being supported by The Alfred’s COVID-19 Positive Community Pathways program last month – part of the coordinated effort to provide oversight, care and support for those quarantining at home.
Clarivate’s 2021 list of Highly Cited Researchers
Seven researchers from Monash Medicine, Nursing and Health Sciences have been named among the world’s most influential researchers in their fields as part of Clarivate’s 2021 list of Highly Cited Researchers.
Monash University – Central Clinical School
Controlling AML maturation can reduce disease relapse
A promising approach to the treatment of acute myeloid leukaemia (AML) has been discovered by AML researchers at the Australian Centre for Blood Diseases.
Neuroscience researchers receive $1.45M from US Department of Defense for research on post-traumatic epilepsy
International funding totalling $1,450,575 from the US Department of Defense (DoD) Epilepsy Research Program has been awarded to early career researchers – Dr Idrish Ali and Dr Pablo Casillas-Espinosa – within the Department of Neuroscience, to each individually advance translational research on post-traumatic epilepsy.
Viertel award for first seizures in epilepsy
Congratulations to Dr Emma Foster, who has been awarded a Viertel Clinical Investigator Award from The Sylvia & Charles Viertel Charitable Foundation, for $90,000.
Baker Heart and Diabetes Institute
Re-setting the clock on heart disease
While the concept of a ‘body clock’ is fairly well established, one laboratory at the Baker Heart and Diabetes Institute is taking things a step further to better understand why people with heart disease have a ‘cardiac clock’ that’s not keeping time.
Let’s talk about genetics and disease – COSMOS
Being told you are genetically predisposed to disease is scary – what does it even mean? Genetics and disease are highly complex and this often means it is hard to navigate whether there is high risk of disease or not. Beyond this, our genetic data can feel personal. So how do we ensure our genetic data is translated responsibly by healthcare providers?
Improved naloxone access can prevent prescription opioid overdose deaths
Making the opioid overdose antidote naloxone easily accessible and available free-of-charge to people who are prescribed opioids in Australia would be cost-effective and save hundreds of lives, new Burnet Institute research demonstrates.
BioAgilytix secures significant new investment from global investor Cinven to fuel continued long-term growth
Investment will provide BioAgilytix with additional resources to invest in core business and drive growth.